Evidence map›Paper›PMID 41568873›Full record

ArticleJournal of the American Society of Nephrology : JASN2026

Laboratory Signs of CKD after Preeclampsia.

Jennifer H Yo, Yuanhang Yang, Aurora Caldinelli, Morgan E Grams, Kate Bramham, Giorgina B Piccoli, Juan-Jesús Carrero, Anna Sara Oberg

Abstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jennifer H YoDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-0618-1813
Yuanhang YangDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-0208-344
Aurora CaldinelliDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.ORCID 0009-0009-6019-9342
Morgan E GramsDepartment of Population Health, New York University Grossman School of Medicine, New York, New York.ORCID 0000-0002-4430-6023
Kate BramhamDepartment of Women and Children's Health, School of Life Course Sciences, King's College London, London, United Kingdom.ORCID 0000-0002-6272-7921
Giorgina B PiccoliDepartment of Internal Medicine, Centre Hospitalier Le Mans, Le Mans, France.ORCID 0000-0002-2632-4009
Juan-Jesús CarreroDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-4763-2024
Anna Sara ObergDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0001-6638-1895

Funding

Medication Use and Adverse Events in CKDR01DK115534 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Alexander R Chang, Morgan Erika Grams · 2018 to 2026
$5.7M
ALF medicine FoUI-986028NIDDK NIH HHS R01 DK115534NIH HHS R01DK115534Region Stockholm 20250416
6 · The paper itself

Abstract

key pointsWomen with preeclampsia had a higher risk of incident albuminuria >300 mg/g, eGFR <60 ml/min per 1.73 m 2 , or the composite outcome. The higher risk extended across multiple outcomes, including CKD diagnoses and nephrology referrals. Despite these risks, postpartum monitoring of kidney function was infrequent, limiting opportunities for early detection and intervention.

backgroundPreeclampsia, a systemic hypertensive disorder of pregnancy, has been associated with the risk of kidney failure, an outcome that may take decades to develop. However, its association with early kidney disease, which could be targeted for intervention, remains underexplored. Here, we quantified the risk of CKD, defined by laboratory markers of kidney damage, in women who had a pregnancy complicated by preeclampsia versus a pregnancy without preeclampsia.

methodsThis was a population-based cohort study in Stockholm, Sweden, using inverse probability of treatment weights to minimize confounding. All nulliparous women who had at least one pregnancy ending in live or stillbirth between January 1, 2006, and December 31, 2020, were identified, excluding preexisting hypertension, diabetes, or CKD. Primary outcomes were ( 1 ) albuminuria defined by urine albumin-creatinine ratio >300 mg/g, ( 2 ) eGFR <60 ml/min per 1.73 m 2 , and ( 3 ) composite of albuminuria >300 mg/g and/or eGFR <60 ml/min per 1.73 m 2 .

resultsThe study included 171,693 pregnancies (170,192 women: mean [SD] age, 29 [5] years), of whom 10,538 (6%) had at least one pregnancy complicated by preeclampsia. During a median follow-up of 7.0 years (interquartile range, 3.3-10.5), albuminuria >300 mg/g occurred after 775 pregnancies (0.5%), eGFR <60 ml/min per 1.73 m 2 occurred after 248 pregnancies (0.1%), and the composite outcome occurred after 985 pregnancies (0.6%). Incidence rates per 1000 person-years were higher after preeclampsia versus no preeclampsia for albuminuria >300 mg/g (1.53 versus 0.57), eGFR <60 ml/min per 1.73 m 2 (0.52 versus 0.18), and the composite outcome (2.00 versus 0.73). Weighted hazard ratios were 2.53 (95% confidence interval [CI], 2.04 to 3.13) for albuminuria >300 mg/g, 2.18 (95% CI, 1.49 to 3.19) for eGFR <60 ml/min per 1.73 m 2 , and 2.43 (95% CI, 2.01 to 2.95) for the composite outcome. In the first postpartum year, 2080 (20%) and 1043 (10%) of women with preeclampsia had serum creatinine or urine albumin testing, respectively.

conclusionsPreeclampsia was associated with a higher risk of laboratory signs of early kidney damage. There were low rates of postpartum kidney function monitoring.

Indexed as

AlbuminuriaPre-EclampsiaRenal Insufficiency, ChronicAdultCohort StudiesCreatinineFemaleGlomerular Filtration RateHumansPregnancySwedenCreatininealbuminuriaCKD

Identifiers

PMID41568873
PMCPMC13337163

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.